埃佛勒斯峰医学研究：血浆中地高辛的测定及其在诊断地高辛中毒中的应用。
Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.
作者信息
Grahame-Smith D G
出版信息
Br Med J. 1969 Feb 1;1(5639):286-9. doi: 10.1136/bmj.1.5639.286.
Abstract
A method for measuring the plasma-digoxin concentration uses the measurement of its inhibitory effect on (86)Rb uptake by human red cells in vitro. Patients receiving digoxin in whom there was no clinical evidence of digoxin intoxication had plasma digoxin concentrations ranging from 0.8 to 4.5 mmug./ml. Patients presenting with convincing clinical evidence of digoxin intoxication had plasma digoxin concentrations ranging from 4 to greater than 8 mmug./ml. It is suggested that the plasma digoxin concentration may be used as an aid in the diagnosis of digoxin intoxication.
摘要
一种测量血浆地高辛浓度的方法是利用体外测量其对人红细胞摄取(86)Rb的抑制作用。接受地高辛治疗但无地高辛中毒临床证据的患者，其血浆地高辛浓度范围为0.8至4.5微克/毫升。出现令人信服的地高辛中毒临床证据的患者，其血浆地高辛浓度范围为4至大于8微克/毫升。有人提出，血浆地高辛浓度可用于辅助诊断地高辛中毒。
相似文献
1
Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.埃佛勒斯峰医学研究：血浆中地高辛的测定及其在诊断地高辛中毒中的应用。
Br Med J. 1969 Feb 1;1(5639):286-9. doi: 10.1136/bmj.1.5639.286.
2
Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.监测地高辛治疗：I. 血浆浓度及组织反应的体外测定
Br J Clin Pharmacol. 1977 Apr;4(2):213-21. doi: 10.1111/j.1365-2125.1977.tb00697.x.
3
Digoxin and digitoxin in man: influence on rubidium transport in red blood cells in vitro.地高辛和洋地黄毒苷对人体的影响：体外对红细胞中铷转运的作用
Acta Cardiol. 1971;26(5):443-57.
4
Plasma concentrations of cardiac glycosides in digitalis intoxication.洋地黄中毒时血浆强心苷的浓度
Eur J Clin Pharmacol. 1972 Jun;4(3):158-61. doi: 10.1007/BF00561139.
5
The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation.
Clin Sci. 1972 Jan;42(1):3P. doi: 10.1042/cs042003pa.
6
The diagnostic value of determination of intraerythrocytic sodium and potassium concentrations versus plasma digoxin concentration in digoxin intoxication.红细胞内钠和钾浓度测定与血浆地高辛浓度测定在地高辛中毒诊断中的价值比较
Acta Med Scand. 1983;213(5):357-62. doi: 10.1111/j.0954-6820.1983.tb03751.x.
7
[Digoxin intoxication in newborns correlation with digoxin plasma concentration (author's transl)].
Monatsschr Kinderheilkd (1902). 1978 Mar;126(3):148-52.
8
Plasma and myocardial digoxin concentrations in patients on oral therapy.接受口服治疗患者的血浆和心肌地高辛浓度
Br Heart J. 1969 Sep;31(5):636-40. doi: 10.1136/hrt.31.5.636.
9
The use of colour vision measurement in the diagnosis of digoxin toxicity.色觉测量在洋地黄中毒诊断中的应用。
Q J Med. 1980;49(195):273-82.
10
In vivo cation transport during short-term and long-term digoxin therapy.短期和长期地高辛治疗期间的体内阳离子转运
Br J Clin Pharmacol. 1986 Jul;22(1):27-30. doi: 10.1111/j.1365-2125.1986.tb02875.x.
引用本文的文献
1
Individualizing therapy - in search of approaches to maximize the benefit of drug treatment (II).个体化治疗——探寻最大化药物治疗益处的方法（二）
Curr Control Trials Cardiovasc Med. 2004 Aug 16;5(1):7. doi: 10.1186/1468-6708-5-7.
2
Digitalis and the cardiac glycosides.洋地黄与强心苷
Br Med J. 1969 Jun 21;2(5659):744-6.
3
Plasma digoxin concentrations and digoxin toxicity in hospital patients.住院患者的血浆地高辛浓度与地高辛毒性
Br Heart J. 1971 Jul;33(4):540-5. doi: 10.1136/hrt.33.4.540.
4
[The elimination of alpha-acetyldigoxin and k-strophanthin in renal insufficiency].
Klin Wochenschr. 1970 Aug 15;48(16):972-8. doi: 10.1007/BF01484400.
5
Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration.地高辛中毒：临床表现与血清地高辛浓度的关系。
J Clin Invest. 1970 Dec;49(12):2377-86. doi: 10.1172/JCI106457.
6
Plasma digoxin concentrations in patients with atrial fibrillation.心房颤动患者的血浆地高辛浓度。
Br Med J. 1970 Aug 22;3(5720):429-32. doi: 10.1136/bmj.3.5720.429.
7
Measurement of plasma digoxin concentration by radioimmunoassay.用放射免疫分析法测定血浆地高辛浓度。
Br Med J. 1970 Aug 22;3(5720):427-8. doi: 10.1136/bmj.3.5720.427.
8
Measuring digoxin.测量地高辛。
Br Med J. 1970 Aug 22;3(5720):416-7.
9
Drug intoxication in renal failure.肾衰竭中的药物中毒
Br Med J. 1970 May 16;2(5706):376-7.
10
Plasma and myocardial digoxin concentrations in patients on oral therapy.接受口服治疗患者的血浆和心肌地高辛浓度
Br Heart J. 1969 Sep;31(5):636-40. doi: 10.1136/hrt.31.5.636.
本文引用的文献
1
A METHOD FOR MEASURING PLASMA LEVELS OF DIGITALIS GLYCOSIDES.一种测定洋地黄苷血浆水平的方法。
Circulation. 1965 Feb;31:228-33. doi: 10.1161/01.cir.31.2.228.
2
The action of cardiac glycosides on sodium and potassium movements in human red cells.强心苷对人体红细胞中钠和钾转运的作用。
J Physiol. 1957 Apr 3;136(1):148-73. doi: 10.1113/jphysiol.1957.sp005749.
3
4
Reappraisal of digitalis. V. Evaluation of criteria for determining effect of digitalis in man.洋地黄的重新评价。V. 确定洋地黄对人体作用的标准的评估。
Am Heart J. 1967 Jan;73(1):134-6. doi: 10.1016/0002-8703(67)90319-5.
5
Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug.接受地高辛治疗的患者血浆、尿液和粪便中地高辛的双同位素稀释衍生测定法。
J Clin Invest. 1966 May;45(5):782-95. doi: 10.1172/JCI105393.
6
The measurement of digitoxin in human serum by radioimmunoassay.采用放射免疫分析法测定人血清中地高辛的含量。
J Clin Invest. 1968 May;47(5):1035-42. doi: 10.1172/JCI105793.
Zotero 插件